Table 3.
Adverse events in stage 2
| Adverse event | Number of adverse events in study | ||
|---|---|---|---|
| Infusion dose (mg/kg) | |||
| 1 | 3 | 6 | |
| hypoglycemia | 5 | 7 | 24 |
| infusion reactions | 0 | 10 | 0 |
| URI | 13 | 16 | 4 |
| diarrhea | 0 | 11 | 0 |
| pyrexia | 1 | 6 | 0 |
| cough | 3 | 4 | 0 |
| sinusitis | 4 | 2 | 0 |
| otitis media | 4 | 2 | 0 |
| skin rash | 1 | 4 | 0 |
| back pain | 3 | 0 | 2 |
| impetigo | 3 | 0 | 2 |
Adverse events listed were observed 5 or more times during course of 52-week study.